Partner Content Partner Content W. J. Wiess and A.S. Lynch invitation to Superbugs & Sup... SMi Group reports: William J.
Views & Analysis Challenging antimicrobial drug resistance with calorimetry Tackling antimicrobial drug resistance with calorimetry.
News ASCO: BMS hails "compelling" phase 3 celmod readout Bristol Myers Squibb has high hopes for its celmod drugs, and a phase 3 trial for mezigdomide in multiple myeloma at ASCO26 has delivered the goods.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
